(Circulation. 1995;92:2327-2332.)
© 1995 American Heart Association, Inc.
Articles |
From the Division of Cardiology, Department of Medicine, University of California, San Diego.
Correspondence to John Ross, Jr, MD, Department of Medicine, 0613B, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0613.
| Abstract |
|---|
|
|
|---|
Key Words: heart rate ventricles heart failure exercise
| Introduction |
|---|
|
|
|---|
Because the relation between LVEDV and LV dP/dtmax was previously shown to be positive and linear and to exhibit an upward shift with increased slope in response to ß-adrenergic stimulation,10 and because LV dP/dtmax (like dF/dt in isolated cardiac muscle15 ) provides a measure of the velocity of contraction and myocardial contractility, provided that the preload is considered, we have relied primarily on dP/dtmax in assessing force-frequency effects.
The force-frequency relation has been shown to be of major importance in the regulation of myocardial contractility in vivo on the basis of recent experiments in conscious animals both during exercise and at rest, as discussed later. These studies indicated that, in addition to the primary intrinsic control of ventricular contractility by neurohormonal ß-adrenergic stimulation, preload and length-dependent activation, and the heart rate under normal conditions, amplification of the force-frequency relation during ß-adrenergic receptor stimulation during stress or severe exercise provides a fourth primary mechanism influencing contractility. Moreover, loss of such adrenergic control of the force-frequency relation may be a significant factor in heart failure.
| Cardiac Responses During Normal Exercise |
|---|
|
|
|---|
| Effect of Heart Rate on Cardiac Contractility and Performance During Exercise |
|---|
|
|
|---|
To study the effects of heart rate alone during exercise, a method was needed in which the normal sequence of AV contraction and normal electric activation of the ventricles could be preserved, obviating the effects of such measures as surgical induction of complete heart block with ventricular pacing or AV sequential pacing. Therefore, we took the approach of controlling the atrial rate by electric stimulation of the atrium after slowing the spontaneous rate with the specific sinus node inhibitor zatebradine (UL-FS 49).19 This agent has been shown to act primarily on the If pacemaker channel20 and to have no direct effect on myocardial contractility.21 22 Thus, contractility changes observed when heart rate is slowed with this agent are mediated only by the force-frequency effect operating in a negative manner.
Experiments were performed in conscious, instrumented dogs trained to
run on a treadmill in which high-fidelity LV pressure and LV
dP/dtmax were measured, together with LV chamber
dimensions and calculated ventricular volumes, by use of
implanted ultrasonic crystals. During strenuous exercise at a heart
rate of 240 bpm, UL-FS 49 was given to slow the exercise heart rate to
<150 bpm while the same level of exercise was continued, which
resulted in a reduction in LV dP/dtmax and an
increase in stroke volume. Heart rate was then immediately returned to
240 bpm by atrial pacing, and all measurements became identical to
those immediately before drug administration, indicating a lack of any
direct effect of UL-FS 49 on myocardial contractility.
With a pacemaker, it was then possible to lower the atrial rate
stepwise for brief periods sufficient to achieve a steady state. Heart
rate was reduced from 240 to 210, 180, and 150 bpm; it was returned to
240 bpm between each step while exercise at a constant level was
continued. A pronounced negative inotropic effect of slowing the heart
rate during exercise was evident, as reflected in a progressive fall in
LV dP/dtmax (Fig 1A
). This occurred
despite a progressive increase of LVEDP and LVEDV (Fig
1B
),19 which alone would be expected to increase
LV
dP/dtmax.9 10 The ESP-ESV relation was
previously shown to be shifted upward and steepened during normal
exercise,16 and slowing the heart rate during exercise
caused the ESP-ESV points to be shifted downward, reflecting an altered
position of the ESP-ESV relation and indicating reduced myocardial
contractility (Fig 1C
).19 These changes,
caused by the force-frequency effect, appeared to account for more
than one half of the positive inotropic effect of exercise, since
ß-adrenergic neurohumoral stimulation to the heart was not likely
to have changed during the brief periods of cardiac slowing during
steady state exercise.
|
| Adrenergic Control of Force-Frequency Effects on LV dP/dtmax |
|---|
|
|
|---|
) was decreased under basal conditions by an increase
in cardiac frequency, and this frequency effect on
was further
magnified by ß-adrenergic stimulation in a dose-dependent
manner.23
|
The importance of a direct myocardial effect of ß-adrenergic receptor stimulation acting together with amplification of the force-frequency relation during exercise is illustrated by experiments with less severe exercise in conscious dogs before and after ß-adrenergic blockade. The resting LV dP/dtmax was reduced, and the early increase of LV dP/dtmax in response to exercise (before the development of regional ischemia in this animal model) was completely prevented by prior ß-adrenergic blockade,24 despite a modest increase in heart rate with exercise. These responses suggest that both direct myocardial ß-adrenergic stimulation and amplification by ß-adrenergic stimulation of the force-frequency effect on myocardial contraction were prevented by ß-blockade.
| Heart Rate and Diastolic Filling During Exercise |
|---|
|
|
|---|
) prolonged at the slowed heart
rate, but an upward shift of the early portion of the LV
diastolic pressure-volume relation occurred (Fig 3
|
| Normal Physiological Control |
|---|
|
|
|---|
|
The mechanisms involved in the force-frequency effects on contractility when heart rate is increased under basal conditions are related primarily to increased Ca2+ availability to the myofilaments. This occurs as a result of enhanced transsarcolemmal Ca2+ influx caused by an increased number of action potentials, corresponding increases in the filling of the SR and augmentation of subsequent Ca2+ transients,27 and the reduced time available for diastolic Ca2+ efflux through the Na+-Ca2+ exchanger.28 A lag in the Na+,K+-ATPase pump leading to a decreased Na+ gradient also appears to contribute.28 Amplification of the force-frequency effect by exercise or ß-adrenergic receptor agonist infusion probably includes a further increase in [Ca2+]i availability owing to phosphorylation of L-type Ca2+ channels by cAMP-dependent protein kinase A, which leads to increased Ca2+ entry,29 and to phosphorylation of phospholamban which causes enhanced SR Ca2+ reuptake, loading, and release.30 The effect on phospholamban also enhances the myocardial relaxation rate. ß-Adrenergic stimulation also causes cAMP-dependent phosphorylation of troponin I with a decrease in myofilament Ca2+ sensitivity. The associated off-loading of Ca2+ from troponin I could contribute further to enhanced myocardial relaxation rate with ß-adrenergic stimulation.31
| Force-Frequency Relations in Heart Failure |
|---|
|
|
|---|
|
Isometrically contracting cardiac muscle taken from failing human
hearts at the time of cardiac transplantation often shows a descending
limb of the relation between increasing contraction frequency and peak
tension.35 Although we failed to find evidence for such a
descending limb in the intact pig based on measurements of contraction
velocity (LV dP/dtmax, Fig 5
),32
a descending limb has been observed in the normal rabbit heart at high
physiological frequencies (>400 bpm) and after
pacing-induced heart failure at lower frequencies (Fig
6
).36 Such a descending limb could
contribute further to dysfunction of the failing heart during stress or
exercise. An important reduction of the force-frequency
amplification by dobutamine infusion also was observed in
the failing rabbit heart in this preliminary report, and the descending
limb at high cardiac frequencies in that species could be largely
prevented by dobutamine infusion (Fig 6
).36
|
Mechanisms of impaired myocardial Ca2+ handling in
heart failure that may be important in abnormal force-frequency
responses are the subject of ongoing study.37
Abnormalities described in myocardium from patients with
end-stage heart failure include impaired
[Ca2+]i transients, indicating reduced
Ca2+ release from the SR and delayed
reuptake,38 a reduction in the number of sarcolemmal
calcium channels,39 and abnormal mRNA levels of
Ca2+ transport proteins, including the
Ca2+ release channel.40 There have been
reports of decreased SR Ca2+ ATPase mRNA
levels,41 although recent evidence suggests that SR
Ca2+ ATPase protein levels are normal in cardiac
muscle from failing human hearts.42 It is possible that
the descending limb of function of the force-frequency relation in
the rabbit, which was more pronounced in heart failure, is related to
impaired function of SR Ca2+ ATPase43
or to delayed mechanical restitution as a consequence of slow recovery
of the Ca2+ release channel.28 With
regard to the latter possibility, it has been shown that mechanical
restitution is slowed in failing rabbit and dog
hearts,44 45 and it is of interest that studies in
normal
isolated papillary muscles show enhancement of mechanical restitution
by ß-adrenergic stimulation46 ; these observations
may relate to the observed correction of the descending limb by
dobutamine infusion (Fig 6
).
A number of steps in the ß-adrenergic stimulation pathway are abnormal in heart failure, including a reduced number of ß-adrenergic receptors and defects in G proteins,38 47 48 which may underlie the observed impairment of ß-adrenergic amplification of the force-frequency effect in heart failure. Better understanding of such mechanisms should lead to improved therapy for the multiple effects of reduced ß-adrenergic stimulation on the failing heart.
In summary, the basic manifestation of the myocardial
force-frequency relation to increase contractility
progressively with higher heart rates has been shown to be subject to
marked enhancement by ß-adrenergic stimulation during normal
exercise or during administration of a ß-adrenergic agonist. In
the clinical setting, reduction of this amplification effect probably
is important in the reduced cardiac response to exercise after
ß-adrenergic blockade and in heart failure when
ß-adrenergic mechanisms are impaired. Also, loss of amplification
of the force-frequency effect during exercise as a consequence of
chronotropic incompetence or heart block undoubtedly contributes to
impaired cardiac responses in these conditions, despite maintained
sympathetic stimulation. Correction of impaired heart rate responses by
rate-responsive pacemakers may help to explain their beneficial
effect on exercise performance. Thus, the fourth major
intrinsic factor regulating myocardial contractility
(Fig 4
) appears to be highly important under normal conditions
and may
be of functional significance in a variety of disease states.
| Selected Abbreviations and Acronyms |
|---|
|
Received February 6, 1995; revision received April 26, 1995; accepted May 10, 1995.
| References |
|---|
|
|
|---|
2. Bowditch HP. Über die eigenthümlichkeiten der reizbarkeit welche die muskelfasern des herzens zeigen. Arb Physiol Aust. 1871;6:139-176.
3.
Koch-Weser J, Blinks JR. The influence of the
interval between beats on myocardial
contractility. Pharmacol Rev. 1963;15:601-652.
4. Buckley NM, Penefsky ZJ, Litwak RS. Comparative force-frequency relationships in human and other mammalian ventricular myocardium. Pflugers Arch. 1972;332:259-270. [Medline] [Order article via Infotrieve]
5.
Covell JW, Ross J Jr, Taylor R, Sonnenblick EH,
Braunwald E. The effects of increasing frequency of contraction
on the force-velocity relation of the left ventricle.
Cardiovasc Res. 1967;1:2-8.
6. Mitchell JH, Wallace AG, Skinner NS Jr. Intrinsic effects of heart rate on left ventricular performance. Am J Physiol. 1963;205:41-48.
7. Higgins CB, Vatner SF, Franklin D, Braunwald E. Extent of regulation of the heart's contractile state in the conscious dog by alteration in the frequency of contraction. J Clin Invest. 1973;52:1189-1194.
8. Mahler F, Yoran C, Ross J Jr. Inotropic effect of tachycardia and poststimulation potentiation in the conscious dog. Am J Physiol. 1974;227:569-575.
9. Mahler F, Ross J Jr, O'Rourke RA, Covell JW. Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. Am J Cardiol. 1975;35:626-633. [Medline] [Order article via Infotrieve]
10.
Little WC. The left ventricular
dP/dtmaxend-diastolic volume
relation in closed-chest dogs. Circ
Res. 1985;56:808-815.
11. Sonnenblick EH, Braunwald E, Williams JF Jr, Glick G. Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative role of changes in heart rate, sympathetic activity, and ventricular dimensions. J Clin Invest. 1965;44:2051-2062.
12. Feldman MD, Alderman JD, Aroesty JM, Royal HD, Ferguson JJ, Owen RM, Grossman W, McKay RG. Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. J Clin Invest. 1988;82:1661-1669.
13.
Suga H, Sagawa K, Shoukas AA. Load independence
of the instantaneous pressure-volume ratio of the canine left
ventricle and effects of epinephrine and heart rate on the
ratio. Circ Res. 1973;32:314-322.
14.
Freeman GL, Little WC, O'Rourke RA. Influence
of heart rate on left ventricular performance in
conscious dogs. Circ Res. 1987;61:455-464.
15. Sonnenblick EH. Force-velocity relations in mammalian heart muscle. Am J Physiol. 1962;202:931-939.
16.
Little WC, Cheng C-P. Effect of exercise on left
ventricular-arterial coupling assessed in
the pressure-volume plane. Am J Physiol. 1993;264:H1629-H1633.
17.
Miyazaki S, Guth BD, Miura T, Indolfi C, Schulz R, Ross
J Jr. Changes of left ventricular
diastolic function in exercising dogs without and with
ischemia. Circulation. 1990;81:1058-1070.
18.
Cheng C-P, Igarashi Y, Little WC. Mechanism of
augmented rate of left ventricular filling during
exercise. Circ Res. 1992;70:9-19.
19.
Miura T, Miyazaki S, Guth BD, Kambayashi M, Ross J Jr.
Influence of the force-frequency relation on left
ventricular function during exercise in conscious
dogs. Circulation. 1992;86:563-571.
20. Goethals M, Raes A, van Bogaert P-P. Use-dependent block of the pacemaker current If in rabbit sinoatrial node cells by zatebradine (UL-FS 49): on the mode of action of sinus node inhibitors. Circulation. 1983;88(part 1):2389-2401.
21.
Guth BD, Heusch G, Seitelberger R, Ross J Jr.
Elimination of exercise-induced regional myocardial
dysfunction by a bradycardiac agent in dogs with coronary
stenosis. Circulation. 1987;75:661-669.
22.
Indolfi C, Guth BD, Miura T, Miyazaki S, Schultz R,
Ross J Jr. Mechanisms of improved ischemic regional
dysfunction by bradycardia. Circulation. 1989;80:983-993.
23.
Kambayashi M, Miura T, Oh B-H, Rockman HA, Murata K,
Ross J Jr. Enhancement of the force-frequency effect on
myocardial contractility by adrenergic stimulation in
conscious dogs. Circulation. 1992;86:572-580.
24. Matsuzaki M, Patritti J, Tajimi T, Miller M, Kemper WS, Ross J Jr. Effects of ß-blockade on regional myocardial flow and function during exercise. Am J Physiol. 1984;247:H52-H60.
25.
Miura T, Miyazaki S, Guth BD, Indolfi C, Ross J Jr.
Heart rate and force-frequency effects on
diastolic function of the left ventricle in exercising
dogs. Circulation. 1994;89:2361-2368.
26. Cheng C-P, Igarashi Y, Little WC. Mechanism of augmented rate of left ventricular filling during exercise. Circ Res. 1992;70:9-19.
27.
Wier WG, Yue DT. Intracellular calcium
transients underlying the short-term force-interval relation in
ferret ventricular myocardium.
J Physiol. 1986;376:507-530.
28. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Norwell, Mass: Kluwer Academic Publishers; 1991:155-158, 167-170.
29. Trautwein W, Heschler J. Regulation of cardiac L-type calcium current by phosphorylation and G proteins. Annu Rev Physiol. 1990;52:257-274. [Medline] [Order article via Infotrieve]
30.
Sasaki T, Inui M, Kimura Y, Kuzuya T, Tada M.
Molecular mechanism of regulation of Ca2+
pump ATPase by phospholamban in cardiac sarcoplasmic reticulum.
J Biol Chem. 1992;267:1674-1679.
31.
Okazaki O, Suda N, Hongo K, Konishi M, Kurihara S.
Modulation of the Ca2+ transients and
contractile properties by ß-adrenoceptor stimulation in ferret
ventricular muscles. J
Physiol. 1990;423:221-240.
32.
Eising GP, Hammond HK, Helmer GA, Gilpin E, Ross J Jr.
Force-frequency relations during heart failure in the
pig. Am J Physiol. 1994;267:H2516-H2522.
33. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billinghan ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and ß-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211. [Abstract]
34.
Cheng C-P, Noda T, Nozawa T, Little WC. Effect
of heart failure on the mechanism of exercise-induced augmentation
of mitral valve flow. Circ Res. 1993;72:795-806.
35.
Mulieri LA, Hasenfuss G, Leavitt B, Allan PD, Alpert
NR. Altered myocardial force-frequency relation in human
heart failure. Circulation. 1992;85:1743-1750.
36. Ryu K-H, Tanaka N, Dalton N, Ross J Jr. Adrenergic responses and the descending limb of force-frequency relations in the failing rabbit heart. FASEB J. 1995;9(pt 1);A558. Abstract.
37. Morgan JP. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med. 1991;325:625-632. [Medline] [Order article via Infotrieve]
38. Gwathmey JK, Slawsky MT, Hajjar RJ, Briggs GM, Morgan JP. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest. 1990;85:1599-1613.
39. Takahashi T, Allen PD, Lacro RV, Marks AR, Dennis AR, Schoen FJ, Grossman W, Marsh JD, Izumo S. Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest. 1992;90:927-935.
40.
Brillantes A-M, Allen P, Takahashi T, Izumo S, Marks
AR. Differences in cardiac calcium release channel (ryanodine
receptor) expression in myocardium from patients with
end-stage heart failure caused by ischemic versus dilated
cardiomyopathy. Circ
Res. 1992;71:18-26.
41. Mercadier J-J, Lompré A-M, Duc P, Boheler KR, Fraysse J-B, Wisnewsky C, Allen PD, Komajda M, Schwartz K. Altered sarcoplasmic reticulum Ca2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 1990;85:305-309.
42.
Movsasian MA, Karimi M, Green K, Jones LR.
Ca2+-transporting ATPase, phospholamban, and
calsequestrin levels in nonfailing and failing human
myocardium. Circulation. 1994;90:653-657.
43. Schwinger RHG, Schmidt U, Bavendiek U, Erdmann E. Ca2+-uptake of sarcoplasmic reticulum plays a functional role for the force-frequency relationship in man. J Am Coll Cardiol. 1995; (February special issue):371A. Abstract.
44.
Ezzaher A, Bouanani NEH, Crozatier B.
Force-frequency relations and response to ryanodine in
failing rabbit hearts. Am J Physiol. 1992;263:H1710-H1715.
45.
Prabhu SD, Freeman GL. Effect of
tachycardia heart failure on the restitution of left
ventricular function in closed-chest dogs.
Circulation. 1995;91:176-185.
46.
Drake-Holland AJ, Sitsapesan R, Herbacznska-Cedro K,
Seed WA, Noble MIM. Effect of adrenaline on cardiac
force-interval relationship. Cardiovasc Res. 1992;26:496-501.
47.
Marzo KP, Frey MJ, Wilson JR, Liang BT, Manning DR,
Lanoce V, Molinoff PB. ß-Adrenergic receptor-G
protein-adenylate cyclase complex in experimental
canine congestive heart failure produced by rapid
ventricular pacing. Circ Res. 1991;69:1546-1556.
48. Roth DA, Urasawa K, Helmer GA, Hammond HK. Downregulation of cardiac guanosine 5'-triphosphate-binding proteins in right atrium and left ventricle in pacing-induced congestive heart failure. J Clin Invest. 1993;91:939-949.
This article has been cited by other articles:
![]() |
M. Kobayashi, H. Izawa, X. W. Cheng, H. Asano, A. Hirashiki, K. Unno, S. Ohshima, T. Yamada, Y. Murase, T. S. Kato, et al. Dobutamine stress testing as a diagnostic tool for evaluation of myocardial contractile reserve in asymptomatic or mildly symptomatic patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. Img., November 1, 2008; 1(6): 718 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-F. Lai, Y.-Z. Chen, L.-P. Feng, X.-M. Meng, J.-F. Ding, L.-Y. Wang, J. Ye, P. Li, X.-S. Cheng, Y. Kitamoto, et al. Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H708 - H716. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ross Jr On the first paper in Cardiovascular Research: Frequency, force, and beyond Cardiovasc Res, August 1, 2007; 75(3): 445 - 447. [Full Text] [PDF] |
||||
![]() |
G. S. Pitt Calmodulin and CaMKII as molecular switches for cardiac ion channels Cardiovasc Res, March 1, 2007; 73(4): 641 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kass Cardiac Resynchronization Therapy and Cardiac Reserve: How You Climb a Staircase May Alter Its Steepness Circulation, February 21, 2006; 113(7): 923 - 925. [Full Text] [PDF] |
||||
![]() |
A. Hudmon, H. Schulman, J. Kim, J. M. Maltez, R. W. Tsien, and G. S. Pitt CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation J. Cell Biol., November 7, 2005; 171(3): 537 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grosu, T. Bombardini, M. Senni, V. Duino, M. Gori, and E. Picano End-systolic pressure/volume relationship during dobutamine stress echo: a prognostically useful non-invasive index of left ventricular contractility Eur. Heart J., November 2, 2005; 26(22): 2404 - 2412. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bombardini, M. Agrusta, N. Natsvlishvili, F. Solimene, R. Pap, F. Coltorti, A. Varga, G. Mottola, and E. Picano Noninvasive assessment of left ventricular contractility by pacemaker stress echocardiography Eur J Heart Fail, March 2, 2005; 7(2): 173 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Takimoto, D. G. Soergel, P. M.L. Janssen, L. B. Stull, D. A. Kass, and A. M. Murphy Frequency- and Afterload-Dependent Cardiac Modulation In Vivo by Troponin I With Constitutively Active Protein Kinase A Phosphorylation Sites Circ. Res., March 5, 2004; 94(4): 496 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ferro, C. Duilio, M. Santomauro, and A. Cuocolo Walk test at increased levels of heart rate in patients with dual-chamber pacemaker and with normal or depressed left ventricular function Eur. Heart J., December 1, 2003; 24(23): 2123 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Korzick REGULATION OF CARDIAC EXCITATION-CONTRACTION COUPLING: A CELLULAR UPDATE Advan Physiol Educ, December 1, 2003; 27(4): 192 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Layland and J. C Kentish Myofilament-based relaxant effect of isoprenaline revealed during work-loop contractions in rat cardiac trabeculae J. Physiol., October 1, 2002; 544(1): 171 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barrere-Lemaire, C. Piot, F. Leclercq, J. Nargeot, and S. Richard Facilitation of L-type calcium currents by diastolic depolarization in cardiac cells: impairment in heart failure Cardiovasc Res, August 1, 2000; 47(2): 336 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Layland and J. C Kentish Effects of {alpha}1- or {beta}-adrenoceptor stimulation on work-loop and isometric contractions of isolated rat cardiac trabeculae J. Physiol., April 1, 2000; 524(1): 205 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Kassiri, R Myers, R Kaprielian, H S Banijamali, and P H Backx Rate-dependent changes of twitch force duration in rat cardiac trabeculae: a property of the contractile system J. Physiol., April 1, 2000; 524(1): 221 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Bluhm, E. G. Kranias, W. H. Dillmann, and M. Meyer Phospholamban: a major determinant of the cardiac force-frequency relationship Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H249 - H255. [Abstract] [Full Text] [PDF] |
||||
![]() |
O.-E. Brodde and M. C. Michel Adrenergic and Muscarinic Receptors in the Human Heart Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schad, W. Heimisch, G. P. Eising, and N. Mendler Effect of dopamine and atrial pacing on stunned myocardium Eur. J. Cardiothorac. Surg., June 1, 1999; 13(6): 710 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Kadambi, N. Ball, E. G. Kranias, R. A. Walsh, and B. D. Hoit Modulation of force-frequency relation by phospholamban in genetically engineered mice Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2245 - H2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Laperche, D Logeart, A Cohen-Solal, and R Gourgon Potential interests of heart rate lowering drugs Heart, April 1, 1999; 81(4): 336 - 341. [Full Text] |
||||
![]() |
M. Meyer, W. F. Bluhm, H. He, S. R. Post, F. J. Giordano, W. Y. W. Lew, and W. H. Dillmann Phospholamban-to-SERCA2 ratio controls the force-frequency relationship Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H779 - H785. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hasenfuss, W. Schillinger, S. E. Lehnart, M. Preuss, B. Pieske, L. S. Maier, J. Prestle, K. Minami, and H. Just Relationship Between Na+-Ca2+–Exchanger Protein Levels and Diastolic Function of Failing Human Myocardium Circulation, February 9, 1999; 99(5): 641 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Spina, M. J. Turner, and A. A. Ehsani beta -Adrenergic-mediated improvement in left ventricular function by exercise training in older men Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H397 - H404. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Richard, F. Leclercq, S. Lemaire, C. Piot, and J. Nargeot Ca2+ currents in compensated hypertrophy and heart failure Cardiovasc Res, February 1, 1998; 37(2): 300 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Neumann, U. Ravens, and G. Heusch Characterization of excitation-contraction coupling in conscious dogs with pacing-induced heart failure Cardiovasc Res, February 1, 1998; 37(2): 456 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R.W. Money-Kyrle, C. H. Davies, H. K. Ranu, P. O'Gara, N. Singh Kent, P. A. Poole-Wilson, and S. E. Harding The role of cAMP in the frequency-dependent changes in contraction of guinea-pig cardiomyocytes Cardiovasc Res, February 1, 1998; 37(2): 532 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Izawa, M. Yokota, Y. Takeichi, M. Inagaki, K. Nagata, M. Iwase, and T. Sobue Adrenergic Control of the Force-Frequency and Relaxation-Frequency Relations in Patients With Hypertrophic Cardiomyopathy Circulation, November 4, 1997; 96(9): 2959 - 2968. [Abstract] [Full Text] |
||||
![]() |
J. Bartunek, A. M. Shah, M. Vanderheyden, and W. J. Paulus Dobutamine Enhances Cardiodepressant Effects of Receptor-Mediated Coronary Endothelial Stimulation Circulation, January 7, 1997; 95(1): 90 - 96. [Abstract] [Full Text] |
||||
![]() |
K. E. Kjorstad, C. Korvald, and T. Myrmel Pressure-volume-based single-beat estimations cannot predict left ventricular contractility in vivo Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1739 - H1750. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |